Bupivacaine Hydrochloride/Adrenaline

盐酸布比卡因/肾上腺素

Report date: 2025/09/26 16:39:28

Base Information

Drug NameBupivacaine Hydrochloride/Adrenaline
Drug Alias NameBupivacainum Hydrochloride布比卡因盐酸盐盐酸布哌卡因Bupivacaine/Epinephrine盐酸丁哌卡因 +[21] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersAdrenergic receptors agonists
TargetsSodium channel alpha subunitAdrenergic receptors
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes Bupivacaine HydrochlorideAdrenaline
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesHospira
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of MedicineHefei Dazhong Pharmaceutical Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG